Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
08/2004
08/10/2004US6774122 Sustained release; injection of fulvestrant
08/10/2004US6773714 Polymeric delivery formulations of leuprolide with improved efficacy
08/05/2004WO2004065419A1 Antibody and use thereof
08/05/2004WO2004064825A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
08/05/2004WO2004064716A2 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders
08/05/2004WO2004029192A3 Producing method of tien hsien liquid
08/05/2004WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking
08/05/2004WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
08/05/2004WO2003059289A3 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
08/05/2004WO2003042359A3 Histamine receptor h3 polynucleotides
08/05/2004WO2002101357A3 Molecular signatures of commonly fatal carcinomas
08/05/2004US20040152960 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
08/05/2004US20040152906 Sulfonamides
08/05/2004US20040152893 Sulfonamides
08/05/2004US20040152891 Sulfonamides
08/05/2004US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases
08/05/2004US20040152779 Bicyclic amino acids as pharmaceutical agents
08/05/2004US20040152761 Dimeric isoflavones
08/05/2004US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors
08/05/2004US20040152753 Methods of use for novel sulfur containing organic nitrate compounds
08/05/2004US20040152751 Viricides; suppress lymphocytes; aids therapy; antiinflammatory agents
08/05/2004US20040152725 Anticancer agents using a compound containing urea group
08/05/2004US20040152717 Urogenital disorders; bleeding; hormone replacement therapy; anticancer agents; contraceptives
08/05/2004US20040152712 sEXUAL DISORDERS; ERECTILE DYSFUNCTION
08/05/2004US20040152709 New compound for the treatment of impotence
08/05/2004US20040152705 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
08/05/2004US20040152692 Pyrrolidine sulfonamides
08/05/2004US20040152688 Aminopyridine derivatives as estrogen receptor modulators
08/05/2004US20040152684 Administering at least one 17 alpha -fluoralkylated progesterone receptor antagonist to the female subject during the post-ovulatory phase of the endometrial cycle inhibiting the occurrence of advanced endometrium maturation
08/05/2004US20040152639 Peptide hormone analogs of GnRH designed to be useful in male and female fertility regulation, post-coital contraception and as a menses-inducing agent, for managing ovarian cyst, polycystic ovarian disease, in vitro fertilization
08/05/2004US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems
08/05/2004US20040152157 G-protein coupled receptors
08/05/2004US20040152143 Growth differentiation factor-9
08/05/2004US20040152134 Eating disorders; sexual disorders; erectile dysfunction
08/05/2004US20040151781 Osteoporosis, hormone-related disorders
08/05/2004US20040151763 pH adjuster namely citric acid, preservative, and an anti-irritant agent, especially a local anesthetic, analgesic, anesthetic, antipruitic, astringent, hydrocortisone preparation, or keratolytic; feminine wipe
08/05/2004CA2514153A1 Antibody and use thereof
08/05/2004CA2513606A1 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
08/04/2004EP1442748A1 Use of FSH for treating infertility
08/04/2004EP1442664A1 A method for supplying biovailable methionine to a cow
08/04/2004EP1442114A2 Novel bacterial poultry disease
08/04/2004EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
08/04/2004EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
08/04/2004EP1442017A1 Preparation of benzosuberonylpiperidine compounds
08/04/2004EP1441770A1 Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility
08/04/2004EP1441769A1 Low concentration of peroxide for treating or preventing vaginal infections
08/04/2004EP1441754A1 Use of egf to inhibit pathogenic infections of the urogenital tract
08/04/2004EP1441752A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
08/04/2004EP1441750A2 Linear and cyclic melanocortin receptor-specific peptides
08/04/2004EP1441724A1 Methods of increasing endogenous testosterone levels
08/04/2004EP1441717A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
08/04/2004EP1441707A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
08/04/2004EP1292586B1 Process for the preparation of pyrazolopyrimidinones
08/04/2004EP1150658B1 Method for controlling liposome size
08/04/2004EP1126879A4 Gene therapy for regulating smooth muscle cell tone
08/04/2004CN1518592A Male contraceptives
08/04/2004CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3
08/04/2004CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors
08/04/2004CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
08/04/2004CN1517349A Two new compounds for treating impotence
08/04/2004CN1517116A Combined Chinese and western herbal medicine vagina bactericidal agent and its preparation method
08/04/2004CN1517115A Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation
08/04/2004CN1517091A Progesterone preparation and its preparation method
08/04/2004CN1160359C Dithiepino [6,5-b] pyridines, and related compsns. and methods for preparing and use
08/04/2004CN1160338C N-[4-(3-chloro-4-fluoro-phenylamino)-7-(-3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases
08/04/2004CN1160105C Supplemented myrrh dragon's blood tablet formula and preparation process thereof
08/04/2004CN1160104C Traditional chinese medicine compostion with blood-enrich, tonifying Qi and warming kidney function
08/04/2004CN1160102C Chinese medicine for curing female chronic inflammation
08/04/2004CN1160089C Propn. method medicine granule for treating hyperprolaction
08/04/2004CN1159984C Prophylactic dietary supplement based on milk
08/03/2004US6770656 Amine derivatives for the treatment of apoptosis
08/03/2004US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient
08/03/2004CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
07/2004
07/29/2004WO2004063761A2 Network-assisted global positioning systems, methods and terminals including doppler shift and code phase estimates
07/29/2004WO2004063221A1 Metastin derivative and use thereof
07/29/2004WO2004062686A2 Therapeutic use of modulators of notch
07/29/2004WO2004062675A1 Method of modulating il-6
07/29/2004WO2004062638A1 Hinokitiol-based composition for personal hygiene care
07/29/2004WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men
07/29/2004WO2004035536A3 Azo compounds for type i phototherapy
07/29/2004WO2004010972A3 Pellicle-resistant gelatin capsule
07/29/2004WO2003099783A3 Tropane compounds
07/29/2004WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators
07/29/2004WO2003086317A3 Protein a compositions and methods of use
07/29/2004WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
07/29/2004WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
07/29/2004US20040147904 Methods and devices for delivery of agents to breast milk ducts
07/29/2004US20040147754 Novel process
07/29/2004US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis
07/29/2004US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering
07/29/2004US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers
07/29/2004US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents
07/29/2004US20040147542 Chemical compounds
07/29/2004US20040147528 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders;
07/29/2004US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
07/29/2004US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists
07/29/2004US20040147511 Prevent premature labor; dymenorrhea
07/29/2004US20040147508 Biologically active methylene blue derivatives
07/29/2004US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse
07/29/2004US20040147451 Animals are injected with an injection solution that contains synthetically produced FSH-releasing hormones with known sequences consisting of 10 amino acids (decapeptide)